Effects of turmeric on uremic pruritus in end stage renal disease patients: A double-blind randomized clinical trial

Journal of Nephrology

Volumn 27, Issue 2, 2014, Pages 203-207

  Pakfetrat, Maryam ^a   Basiri, Fatemeh ^a   Malekmakan, Leila ^a   Roozbeh, Jamshid ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clinical trial; End stage renal disease; Hemodialysis; Turmeric; Uremic pruritus

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; PLACEBO; TURMERIC; PLANT MEDICINAL PRODUCT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PARALLEL DESIGN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCRATCHING; SLEEP DISORDER; UREMIC PRURITUS; AGED; BLOOD; COMPLICATION; CURCUMA; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PHYTOTHERAPY; RENAL REPLACEMENT THERAPY; RHIZOME; SEVERITY OF ILLNESS INDEX; UREMIA;

ADULT; AGED; C-REACTIVE PROTEIN; CURCUMA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; PRURITUS; RENAL DIALYSIS; RHIZOME; SEVERITY OF ILLNESS INDEX; UREMIA;

EID: 84901014342     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0039-2     Document Type: Article

References (36)

1. Manenti L, Tansinda P, Vaglio A (2009) Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs 69(3):251-263
2. Narita I, Iguchi S, Omori K, Gejyo F (2008) Uremic pruritus in chronic hemodialysis patients. J Nephrol 21(2):161-165
3. Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G (2005) Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 152: 289-295
4. Marquez D, Ramonda C, Lauxmann JE, Romero CA, Vukelic VL, Martinatto C, Barron B, Novoa PA, Peixoto AJ, Orías M (2012) Uremic pruritus in hemodialysis patients: treatment with desloratidine versus gabapentin. J Bras Nefrol 34(2):148-152
5. Vila T, Gommer J, Scates AC (2008) Role of gabapentin in the treatment of uremic pruritus. Ann Pharmacother 42(7):1080-1084
6. Murphy M, Reaich D, Pai P, Finn P, Carmichael AJ (2003) A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch. Br J Dermatol 148(2):314-317
7. Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR (1994) Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 67(3):270-273
8. Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M (2005) Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 16(12):3742-3747
9. Ko MJ, Yang JY, Wu HY, Hu FC, Chen SI, Tsai PJ, Jee SH, Chiu HC (2011) Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial. Br J Dermatol 165(3):633-639
10. Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y (2004) A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 19(7):1895-1901
11. Chiu YL, Chen HY, Chuang YF, Hsu SP, Lai CF, Pai MF, Yang SY, Peng Y (2008) Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant 23(11):3685-3689
12. Chen HY, Chiu YL, Hsu SP, Pai MF, Lai CF, Yang JY, Peng YS, Tsai TJ, Wu KD (2010) Elevated C-reactive protein level in hemodialysis patients with moderate/severe uremic pruritus: a potential mediator of high overall mortality. QJM 103(11):837-846
13. Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, Stulten C, van der Kuip H, Pauli-Magnus C, Raub U, Kuhlmann U, Mettang T (2006) The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 21(3):749-755
14. Baliga MS, Katiyar SK (2006) Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem Photobiol Sci 5(2):243-253
15. Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1-75
16. Roberto M, Roberta F, Rekha B, Colin JG (2000) Curcumin, an antioxidant and anti-inflammatory agent induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 28:1303-1312
17. Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75(4):787-809
18. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631-1652
19. Duo LJ (1987) Electrical needle therapy of uremic pruritus. Nephron 47(3):179-183
20. He X-G, Lin L-Z, Lian L-Z, Lindenmaier M (1998) Liquid chromatography-electrospray mass spectrometric analysis of curcuminoids and sesquiterpenoids in turmeric (Curcuma longa). J Chromatogr A 818:127-132
21. Wikström B (2007) Itchy skin-a clinical problem for haemodialysis patients. Nephrol Dial Transplant 22(Suppl 5):3-7
22. Duque MI, Thevarajah S, Chan YH, Tuttle AB, Freedman BI, Yosipovitch G (2006) Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol 66(3): 184-191
23. Fallahzadeh MK, Roozbeh J, Geramizadeh B, Namazi MR (2011) Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications. Nephrol Dial Transplant 26(10):3338-3344
24. Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, Kondo D, Skatsume M, Maruyama S, Kazama JJ, Akazawa K, Gejyo F (2006) Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 69(9):1626-1632
25. Floege J, Schäffer J, Koch KM, Shaldon S (1992) Dialysis related amyloidosis: a disease of chronic retention and inflammation? Kidney Int Suppl 38:78-85
26. Yeun JY, Levine RA, Mantadilok V, Kaysen GA (2000) C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35(3):469-476
27. Tripepi G, Mallamaci F, Zoccali C (2005) Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16(Suppl 1):83-88
28. Lugon JR (2005) Uremic pruritus: a review. Hemodial Int 9(2):180-188
29. Aoki R, Kawamura T, Goshima F, Ogawa Y, Nakae S, Nakao A, Moriishi K, Nishiyama Y, Shimada S (2013) Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production. J Invest Dermatol 133:2170-2179
30. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787-793
31. Jurenka JS (2009) Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 14(2):141-153
32. Aggarwal BB, Gupta SC, Sung B (2013) Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol 169:1672-1692
33. Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T (2006) Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 4(12):1502-1506
34. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK (2003) Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 139(2):209-218
35. Fan X, Zhang C, Liu DB, Yan J, Liang HP (2013) The clinical applications of curcumin: current state and the future. Curr Pharm Des 19(11):2011-2031
36. Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H (2004) Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 19(12):3137-3139